Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men

Atherosclerosis

Volumn 167, Issue 2, 2003, Pages 311-317

  Skoglund Andersson, Camilla ^a   Ehrenborg, Ewa ^a   Fisher, Rachel M ^a   Olivecrona, Gunilla ^b   Hamsten, Anders ^a   Karpe, Fredrik ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Apolipoprotein E; Cholesteryl ester transfer protein; Hepatic lipase; Lipoprotein lipase; Low density lipoproteins; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; POLYACRYLAMIDE GEL;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FRACTIONATION; GEL ELECTROPHORESIS; GENE; GENE INTERACTION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PARTICLE SIZE; PLASMA FACTOR; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN VARIANT;

EID: 0038802829     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00016-9     Document Type: Article

References (33)

1. Austin M.A. Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype. Curr. Atheroscler. Rep. 2:(3):2000;200-207.
2. Austin M.A., Talmud P.J., Luong L.A., et al. Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am. J. Hum. Genet. 62:(2):1998;406-419.
3. Talmud P.J., Edwards K.L., Turner C.M., Newman B., Palmen J.M., Humphries S.E., Austin M.A. Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoter. Circulation. 101:(21):2000;2461-2466.
4. Allayee H., Aouizerat B.E., Cantor R.M., et al. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. Am. J. Hum. Genet. 63:(2):1998;577-585.
5. Allayee H., Dominguez K.M., Aouizerat B.E., et al. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. J. Lipid Res. 41:(2):2000;245-252.
6. Austin M.A., Stephens K., Walden C.E., Wijsman E. Linkage analysis of candidate genes and the small, dense low-density lipoprotein phenotype. Atherosclerosis. 142:(1):1999;79-87.
7. Rainwater D.L., Almasy L., Blangero J., Cole S.A., VandeBerg J.L., MacCluer J.W., Hixson J.E. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler. Thromb. Vasc. Biol. 19:(3):1999;777-783.
8. Yamashita S., Hirano K., Sakai N., Matsuzawa Y. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim. Biophys. Acta. 1529:(1-3):2000;257-275.
9. Dachet C., Poirier O., Cambien F., Chapman J., Rouis M. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler. Thromb. Vasc. Biol. 20:(2):2000;507-515.
10. Ordovas J.M., Cupples L.A., Corella D., et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler. Thromb. Vasc. Biol. 20:(5):2000;1323-1329.
11. Wittrup H.H., Tybjaerg-Hansen A., Nordestgaard B.G. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation. 99:(22):1999;2901-2907.
12. Gagne S.E., Larson M.G., Pimstone S.N., et al. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin. Genet. 55:(6):1999;450-454.
13. Santamarina-Fojo S., Haudenschild C., Amar M. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr. Opin. Lipidol. 9:(3):1998;211-219.
14. Guerra R., Wang J., Grundy S.M., Cohen J.C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94:(9):1997;4532-4537.
15. Jansen H., Verhoeven A.J., Weeks L., et al. Common C- to -T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler. Thromb. Vasc. Biol. 17:(11):1997;2837-2842.
16. Murtomaki S., Tahvanainen E., Antikainen M., Tiret L., Nicaud V., Jansen H., Ehnholm C. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler. Thromb. Vasc. Biol. 17:(10):1997;1879-1884.
17. Zambon A., Deeb S.S., Hokanson J.E., Brown B.G., Brunzell J.D. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler. Thromb. Vasc. Biol. 18:(11):1998;1723-1729.
18. Jansen H., Chu G., Ehnholm C., Dallongeville J., Nicaud V., Talmud P.J. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler. Thromb. Vasc. Biol. 19:(2):1999;303-308.
19. Couture P., Otvos J.D., Cupples L.A., Lahoz C., Wilson P.W., Schaefer E.J., Ordovas J.M. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 20:(3):2000;815-822.
20. Deeb S.S., Peng R. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J. Lipid Res. 41:(1):2000;155-158.
21. Haffner S.M., Stern M.P., Miettinen H., Robbins D., Howard B.V. Apolipoprotein E polymorphism and LDL size in a biethnic population. Arterioscler. Thromb. Vasc. Biol. 16:1996;1184-1188.
22. Wilson P.W.F., Schaefer E.J., Larson M.G., Ordovas J.M. Apolipoprotein E alleles and risk of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 16:1996;1250-1255.
23. Carlson K. Lipoprotein fractionation. J. Clin. Pathol. 5:1973;32-37.
24. Skoglund-Andersson C., Tang R., Bond M.G., de Faire U., Hamsten A., Karpe F. LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. Arterioscler. Thromb. Vasc. Biol. 19:(10):1999;2422-2430.
25. Karpe F., Olivecrona T., Walldius G., Hamsten A. Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. J. Lipid Res. 33:(7):1992;975-984.
26. Groenemeijer B.E., Hallman M.D., Reymer P.W., et al. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation. 95:(12):1997;2628-2635.
27. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:(3):1990;545-548.
28. Bernard S., Moulin P., Lagrost L., et al. Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. J. Lipid Res. 39:(1):1998;59-65.
29. Carr M.C., Ayyobi A.F., Murdoch S.J., Deeb S.S., Brunzell J.D. Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women. Arterioscler. Thromb. Vasc. Biol. 22:(4):2002;667-673.
30. Henderson H.E., Kastelein J.J., Zwinderman A.H., et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J. Lipid Res. 40:(4):1999;735-743.
31. Garenc C., Perusse L., Gagnon J., et al. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: the HERITAGE Family Study. Metabolism. 49:(4):2000;432-439.
32. Schaefer E.J., Lamon-Fava S., Johnson S., Ordovas J.M., Schaefer M.M., Castelli W.P., Wilson P.W. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler. Thromb. 14:(7):1994;1105-1113.
33. Nikkilä M., Pitkäjärvi T., Koivula T., et al. Women have larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis. 119:1996;181-190.